Üreticilere, Bölgelere, Tipe ve Uygulamaya Göre ABD İkincil Hiperparatiroidizm Tedavi Pazarı 2021, 2026’ya Kadar Tahmin

US Secondary Hyperparathyroidism Treatment Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis Industry Forecast 2021 To 2027 is latest report published on “Global U.S Secondary Hyperparathyroidism Treatment Market” by Fortune Business Insights. The global robotaxi market size was USD 4.34 billion in 2018. The global impact of COVID-19 pandemic has been unprecedented and staggering, with robotaxi witnessing a positive demand across all regions amid the pandemic. Based on our analysis, the global commercial vehicle market size is projected to reach USD 7.06 billion by the end of 2026. The increasing IT sector and rapid industrialization across the globe will emerge in favor of market growth.

To Understand U.S Secondary Hyperparathyroidism Treatment Key Trends, Download Sample Report:

www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-secondary-hyperparathyroidism-shpt-treatment-market-101664

U.S Secondary Hyperparathyroidism Treatment Top Companies Analyzed in the report:

  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Genzyme Corporation (Sanofi)
  • AbbVie Inc.
  • Cipla Inc.
  • Reddy’s Laboratories Ltd.
  • OPKO Health, Inc.
  • Other Prominent Players

Rising Prevalence Of Chronic Kidney Disease Will Stimulate Growth 

The increasing prevalence of chronic kidney disease among geriatric population as well as general population will enable the growth of the secondary hyperparathyroidism treatment market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 15% of U.S adults, which, is, 37 million people are estimated to have chronic kidney disease. Additionally, CKD is found more common in people aged 65 years or older than in people aged 45-64 years. The rising cases of renal disease and increasing patient pool will have a significant impact on the market. The increasing cost burden for the treatment of secondary hyperparathyroidism will further encourage growth of the market. In addition, the launch of generic form of Cinacalcet hydrochloride tablets will bode well for the secondary hyperparathyroidism treatment market. For instance, Cipla Inc. and its subsidiary Cipla USA Inc. announced the launch of a generic form of Cinacalcet hydrochloride tablets in USA. Moreover, Amgen Inc. announced the USFDA approval of Parsabiv for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD). The approval for Parsabiv will also aid the growth of the market during the forecast period.

Emerging Guidelines By Government Authorities Will Boost Growth

The increasing government initiatives for improvising secondary hyperparathyroidism management will create growth opportunities for the secondary hyperparathyroidism treatment market. The aim of SHPT treatment is to manage the biochemical markers of bone and mineral metabolism, which are directly linked to cardiovascular events and bone fractures by extensive epidemiologic evidence. International & national organizations in the U.S. and working groups such as the National Kidney Foundation have published various clinical guidance documents to encourage best practices in managing SHPT. Furthermore, increasing awareness about SHPT in physicians, as well as clinical specialists, have improved the treatment regimen for its management. The improvement in earlier identification and assessment of SHPT for mineral metabolism in CKD & ESRD will have a positive impact on secondary hyperparathyroidism treatment market growth. The reduction in associated complications for the management of SHPT is expected to accelerate growth of the market during the forecast period.

Key questions answered in the report:

  • What will the market growth rate of U.S Secondary Hyperparathyroidism Treatment market in 2027?
  • What are the key factors driving the global U.S Secondary Hyperparathyroidism Treatment market?
  • Who are the key manufacturers in U.S Secondary Hyperparathyroidism Treatment market space?
  • What are the market opportunities, market risk and market overview of the U.S Secondary Hyperparathyroidism Treatment market?
  • What are sales, revenue, and price analysis of top manufacturers of U.S Secondary Hyperparathyroidism Treatment market?
  • Who are the distributors, traders and dealers of U.S Secondary Hyperparathyroidism Treatment market?
  • What are the U.S Secondary Hyperparathyroidism Treatment market opportunities and threats faced by the vendors in the global U.S Secondary Hyperparathyroidism Treatment industry?
  • ABD İkincil Hiperparatiroidizm Tedavisi pazarının türlerine ve uygulamalarına göre satış, gelir ve fiyat analizi nedir?
  • ABD İkincil Hiperparatiroidizm Tedavisi endüstrisinin bölgelerine göre sat??, gelir ve fiyat analizi nedir?

Herhangi bir sorunuz mu var? Uzmanlarımıza Sorun:

www.fortunebusinessinsights.com/enquiry/speak-to-analyst/us-secondary-hyperparatiroidism-shpt-treatment-market-101664

İçerik tablosu:

  1. Tanıtım

1.1. Araştırma Kapsamı

1.2. Pazar Segmentasyonu

1.3. Araştırma Metodolojisi

1.4. Tanımlar ve Varsayımlar

  1. Yönetici Özeti
  2. Pazar Dinamikleri

3.1. Market sürücüleri

3.2. Pazar Kısıtlamaları

  1. Temel bilgiler

4.1 Birleşme, Devralmalar ve Ortaklıklar

4.2 Büyüme ve Penetrasyon Analizi

4.3 Porter’ın Beş Kuvvet Analizi

4.4 PEST Analizi

4.5 ABD Sekonder Hiperparatiroidi Tedavisinde Teknolojik Gelişmeler

4.6 Covid-19 Etki Analizi

Devam etti…

Hakkımızda:

Fortune Business Insights™ uzman kurumsal analiz ve doğru veriler sunarak her büyüklükteki kuruluşun zamanında kararlar almasına yardımcı olur. Müşterilerimiz için yenilikçi çözümler tasarlayarak, onların işlerine özgü zorlukları çözmelerine yardımcı oluyoruz. Amacımız, faaliyet gösterdikleri pazara ayrıntılı bir genel bakış sunarak müşterilerimizi bütünsel pazar istihbaratıyla güçlendirmektir.

Raporlarımız, şirketlerin sürdürülebilir büyüme elde etmesine yardımcı olmak için benzersiz bir somut içgörü ve niteliksel analiz karışımı içerir. Deneyimli analistler ve danışmanlardan oluşan ekibimiz, ilgili verilerle serpiştirilmiş kapsamlı pazar araştırmalarını derlemek için sektör lideri araştırma araçlarını ve tekniklerini kullanır.

Bizimle iletişime geçin:

Fortune Business Insights Pvt. Ltd.

308, Yüksek Karargah,

Anket No. 36, Baner,

Pune-Bangalore Otoyolu,

Pune -411045, Maharashtra, Hindistan.

ABD: +1 424 253 0390

İngiltere: +44 2071 939123

APAC: +91 744 740 1245